Fougamou [23]
|
Gabon, 2007–2008
|
msp1,msp2,glurp
|
68/68
|
Sanofi-Aventis (FDC Coarsucam) 30 mg/kg
|
11.6 (6.0–16.8)
|
13.1 (7.6–18.6)
|
0.6
|
2.3 (1.1–4.2)
|
0.5
|
79.5 [30]
|
97.9 [31]
|
Ndola [23]
|
Zambia, 2007–2009
|
msp1,msp2,glurp
|
69/64
|
Sanofi-Aventis (FDC Coarsucam) 30 mg/kg
|
10.8 (6.0–14.8)
|
16.1 (9.7–25.0)
|
1.2
|
4.8 (2.4–8.4)
|
1.0
|
No matching survey
|
20.8 [32]
|
Pweto [33]
|
Democratic Republic of Congo 2008-2009
|
msp1,msp2,glurp
|
126/129
|
Sanofi-Aventis (AS-AQ Winthrop FDC) 30 mg/kg
|
11.3 (7.8–14.4)
|
17.9 (12.1–25.6)
|
50.0
|
9.3 (6.2–13.7)
|
2.0
|
No matching survey
|
No matching survey
|
Pamol [23]
|
Nigeria, 2007–2008
|
msp1,msp2,glurp
|
164/159
|
Sanofi-Aventis (FDC Coarsucam) 30 mg/kg
|
17.9 (12.3–22.5)
|
15.4 (10.3–21.7)
|
22.6
|
9.5 (4.7–21.6)
|
2.2
|
61.8 [34,35,36]
|
90.1 [37]
|
Bobo Dioulasso (unpublished‡)
|
Burkina Faso, 2010–2012
|
msp1,msp2
|
373/372
|
Sanofi-Aventis (FDC Coarsucam) 30 mg/kg
|
12.5 (10.6–14.4)
|
16.9 (14.0–19.9)
|
21.5
|
17.4 (13.3–23.1)
|
5.9
|
18.0 [38, 39]
|
28.5 [38,39,40,41,42]
|
Gourcy (unpublished‡)
|
Burkina Faso, 2010–2012
|
msp1,msp2
|
112/129
|
Sanofi-Aventis (FDC Coarsucam) 30 mg/kg
|
8.7 (6.2–10.9)
|
17.8 (13.7–22.1)
|
22.9
|
23.3 (15.9–33.7)
|
6.5
|
18.0 [38, 39]
|
24.8 [39, 41]
|
Kisumu (unpublished‡)
|
Kenya, 2005
|
msp1,msp2
|
179/178
|
Sanofi and Hoechst Marion Roussel (Loose NFDC) 30 mg/kg
|
18.6 (15.8–21.2)
|
14.2 (10.9–17.6)
|
6.9
|
26.5 (18.1–39.6)
|
5.7
|
66.6 [43,44,45,46]
|
90.3 [44, 46, 47]
|
Nimba [48]
|
Liberia, 2008–2009
|
msp1,msp2,glurp
|
127/141
|
Sanofi-Aventis (AS-AQ Winthrop FDC) 30 mg/kg
|
17.9 (15.1–20.6)
|
11.6 (8.8–14.3)
|
18.3
|
32.4 (26.1–40.0)
|
8.0
|
69.4 [49]
|
93.5 [49]
|
Sikasso [50]
|
Mali 2005-2007
|
msp1,msp2,CA1
|
236/233
|
Sanofi-Aventis (Coblistered NFDC. Arsucam) 30 mg/kg
|
10.2 (9.0–11.6)
|
18.7 (16.1–21.5)
|
25.2
|
37.2 (29.5–46.9)
|
11.3
|
35.5 [51]
|
70.2 [32, 51,52,53,54]
|
Tororo [55]
|
Uganda, 2009–2010
|
msp1,msp2,glurp
|
190/190
|
Sanofi (AS-AQ Winthrop FDC) 30 mg/kg
|
13.3 (11.8–14.6)
|
13.4 (11.7–15.1)
|
23.3
|
84.2 (72.9–96.9)
|
16.9
|
63.9 [56,57,58]
|
99.6 [56, 58]
|
Nanoro [23]
|
Burkina Faso, 2007–2008
|
msp1,msp2,glurp
|
257/273
|
Sanofi-Aventis (FDC Coarsucam) 30 mg/kg
|
10.1 (9.2–11.1)
|
17.0 (15.0–19.2)
|
52.2
|
91.9 (76.2–111.1)
|
18.9
|
31.6 [38, 59]
|
67.0 [32, 38, 42, 59]
|
Tororo [60]
|
Uganda, 2005
|
msp1,msp2
|
189/195
|
AQ: Parke-David, Pfizer, AS: Sanofi-Aventis (Loose NFDC) 25 mg/kg
|
12.4 (11.1–13.8)
|
10.2 (8.9–11.6)
|
64.6
|
117.1 (98.4–139.8)
|
23.3
|
79.4 [56, 61]
|
96.2 [62, 63]
|